As of January 2026 Inozyme Pharma has a market cap of $0.25 Billion USD. This makes Inozyme Pharma the world's 8189th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.